We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16B
AUM Growth
-$1.05B
Cap. Flow
-$192M
Cap. Flow %
-1.2%
Top 10 Hldgs %
35.77%
Holding
1,457
New
38
Increased
735
Reduced
275
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 60.21%
2 Technology 9.75%
3 Consumer Discretionary 4.32%
4 Healthcare 3.56%
5 Financials 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
1276
4D Molecular Therapeutics
FDMT
$515M
$1K ﹤0.01%
94
GBIO
1277
DELISTED
Generation Bio
GBIO
$1K ﹤0.01%
19
GERN icon
1278
Geron
GERN
$930M
$1K ﹤0.01%
684
IDYA icon
1279
IDEAYA Biosciences
IDYA
$3.48B
$1K ﹤0.01%
132
IMA
1280
ImageneBio Inc
IMA
$65.5M
$1K ﹤0.01%
9
KALV
1281
DELISTED
KalVista Pharmaceuticals
KALV
$1K ﹤0.01%
46
KNSA icon
1282
Kiniksa Pharmaceuticals
KNSA
$6.11B
$1K ﹤0.01%
60
KOD icon
1283
Kodiak Sciences
KOD
$2.52B
$1K ﹤0.01%
151
KPTI icon
1284
Karyopharm Therapeutics
KPTI
$161M
$1K ﹤0.01%
9
KRON
1285
DELISTED
Kronos Bio
KRON
$1K ﹤0.01%
164
LXRX icon
1286
Lexicon Pharmaceuticals
LXRX
$1.04B
$1K ﹤0.01%
434
MRSN
1287
DELISTED
Mersana Therapeutics
MRSN
$1K ﹤0.01%
10
NKTX icon
1288
Nkarta
NKTX
$159M
$1K ﹤0.01%
113
OCUL icon
1289
Ocular Therapeutix
OCUL
$1.85B
$1K ﹤0.01%
262
OLMA icon
1290
Olema Pharmaceuticals
OLMA
$1.01B
$1K ﹤0.01%
118
OMER icon
1291
Omeros
OMER
$816M
$1K ﹤0.01%
214
ORIC icon
1292
Oric Pharmaceuticals
ORIC
$1.23B
$1K ﹤0.01%
135
PAHC icon
1293
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
PASG icon
1294
Passage Bio
PASG
$14.7M
$1K ﹤0.01%
9
PGEN icon
1295
Precigen
PGEN
$1.97B
$1K ﹤0.01%
708
PHAT icon
1296
Phathom Pharmaceuticals
PHAT
$930M
$1K ﹤0.01%
92
PLRX icon
1297
Pliant Therapeutics
PLRX
$66.3M
$1K ﹤0.01%
123
PRAX icon
1298
Praxis Precision Medicines
PRAX
$8.25B
$1K ﹤0.01%
9
PRLD icon
1299
Prelude Therapeutics
PRLD
$370M
$1K ﹤0.01%
104
PSNL icon
1300
Personalis
PSNL
$1.27B
$1K ﹤0.01%
152

Similar funds

Daiwa Securities Group's Q1 2022 Portfolio in Review

As of Q1 2022, Daiwa Securities Group held 1,457 positions worth $16B, down 6.2% from $17B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q1 2022 filing shows 38 new, 735 increased, 275 reduced and 40 closed positions. Its largest new stake was Federal Realty Investment Trust: 21,861 shares worth $2.67M. The largest sale was Ventas, an estimated $181M.

By sector, the portfolio is most concentrated in Real Estate at 60% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2022 buy was Federal Realty Investment Trust: 21,861 shares worth $2.67M.
  • Daiwa Securities Group added most to Invitation Homes in Q1 2022, an estimated $216M increase.
  • Daiwa Securities Group's biggest Q1 2022 reduction was Ventas, cutting an estimated $181M.
  • Daiwa Securities Group fully exited Xilinx Inc in Q1 2022, selling an estimated $4.54M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $16B portfolio in Q1 2022.
  • Daiwa Securities Group opened 38 new positions and closed 40 in Q1 2022.
  • Daiwa Securities Group's portfolio value fell 6.2% quarter-over-quarter to $16B.

Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.